You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 61 No. 11, November 2004 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (3)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Aging/ Geriatrics
 •Neuropathology
 •Alert me on articles by topic

Reduced Brain Delivery of Homovanillic Acid to Cerebrospinal Fluid During Human Aging

Stanley I. Rapoport, MD; Mark B. Schapiro, MD; Conrad May, MD

Arch Neurol. 2004;61:1721-1724.

Background  Markers of human brain dopamine metabolism are reported to decline with age. However, the cerebrospinal fluid (CSF) concentration of homovanillic acid (HVA), a major dopamine metabolite, is reported to not change or to increase in elderly individuals.

Objective  To estimate the rate of delivery of HVA from the brain to CSF, taking into account the HVA concentration gradient in the spinal subarachnoid space and CSF flow.

Methods  Homovanillic acid concentrations were measured in 5 serial 6-mL aliquots of CSF removed from the L3-4 or L4-5 interspaces of 7 healthy young (mean ± SD age, 28.7 ± 4.6 years) subjects and 7 healthy elderly (mean ± SD age, 77.1 ± 6.3 years) subjects. Cisterna magna HVA concentrations were estimated from the slopes of the HVA concentrations along the spinal subarachnoid space. The products of cisternal HVA concentrations and published values for CSF flow were used to estimate lower limits for brain delivery of HVA to CSF, according to the Fick principle.

Results  The mean ± SD HVA concentration in the initial lumbar CSF sample in the young subjects, 116 ± 66 pmol/mL, did not differ significantly from 140 ± 86 pmol/mL in the elderly subjects. Estimated cisternal HVA concentrations equaled 704 and 640 pmol/mL, respectively, in the young and elderly subjects. Multiplying these concentrations by CSF flow rates of 591 and 294 mL/d, respectively, gave lower limits for rates of delivery of HVA from the brain to CSF. These rates equaled 416 and 175 nmol/d, respectively.

Conclusion  A 50% decline in the lower limit for the rate of HVA delivery from the brain to CSF in elderly individuals is consistent with other evidence that brain dopaminergic neurotransmission declines with age.


Author Affiliations: Section on Brain Physiology and Metabolism, National Institute on Aging, National Institutes of Health, Bethesda, Md (Drs Rapoport, Schapiro, and May); Department of Pediatrics and Division of Neurology, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio (Dr Schapiro); and VA Medical Health Care System, Baltimore, Md (Dr May).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Homocysteine and methylmalonic acid concentrations in cerebrospinal fluid: relation with age and Alzheimer's disease
Serot et al.
J. Neurol. Neurosurg. Psychiatry 2005;76:1585-1587.
ABSTRACT | FULL TEXT  

Brain Delivery of Homovanillic Acid to Cerebrospinal Fluid During Human Aging
Marti et al.
Arch Neurol 2005;62:690-690.
FULL TEXT  

Brain Delivery of Homovanillic Acid to Cerebrospinal Fluid During Human Aging--Reply
Rapoport et al.
Arch Neurol 2005;62:690-691.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.